Maxime Guéguinou

6PUBLICATIONS
34CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 20, 2026
Mitochondria-Targeting Moieties Based on N-Tethered Pyridinium Cations.

|Nov 02, 2024
Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling.

Maryne Dupuy, Maxime Gueguinou, Anaïs Postec

|Aug 20, 2024
Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.

Sarah Proteau, Imène Krossa, Chrystel Husser

|Nov 15, 2023
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.

Sarah Proteau, Imène Krossa, Chrystel Husser

|May 08, 2022
Curcumin and NCLX inhibitors share anti-tumoral mechanisms in microsatellite-instability-driven colorectal cancer.

Maxime Guéguinou, Sajida Ibrahim, Jérôme Bourgeais

|Jun 25, 2021
Panitumumab and cetuximab affect differently miRNA expression in colorectal cancer cells.

Romain Chautard, Laetitia Corset, Sajida Ibrahim

Pageof 1

Frequent Collaborators

2 joint publications

Nathalie M Mazure

2 joint publications

Solange Landreville

2 joint publications

Patrick Brest

2 joint publications

Thomas Strub